Eagle Pharmaceuticals, Inc.'s (EGRX) CEO Scott Tarriff on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
Eagle Pharmaceuticals (EGRX) Q1 Earnings and Revenues Miss EstimatesZacks Investment Research • 05/10/21
Eagle Pharmaceuticals Announces Filing of TREAKISYM (bendamustine) Rapid Infusion (“RI”) Liquid Formulation in JapanBusiness Wire • 05/10/21
Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of DirectorsBusiness Wire • 05/03/21
Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination with Rituximab for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma Receives PMDA Approval in JapanBusiness Wire • 04/30/21
Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021Business Wire • 04/29/21
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/02/21
Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline ReviewBusiness Wire • 03/02/21
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021Business Wire • 02/22/21
Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin TrialBusiness Wire • 02/02/21
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date PostponedBusiness Wire • 02/01/21
SEEDS - Access Changes Everything Announces Multi-Year Partnership with Eagle PharmaceuticalsPRNewsWire • 01/28/21
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 ConcernsBusiness Wire • 01/11/21
Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/04/21
Eagle Pharmaceuticals' Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for ViewingBusiness Wire • 11/23/20
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/02/20
Eagle Pharmaceuticals (EGRX) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/02/20
Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future GrowthBusiness Wire • 11/02/20
Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020Business Wire • 10/26/20